Canadian application, no grantCanada
Use of sarp-1 for the treatment and/or prevention of scleroderma
CA 2428092 A1 · Owner: Applied Research Systems Ars Holding N.V. · Inventors: Power, Christine; Plater-Zyberk, Christine; Colinge, Jacques
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the use of SARP-1 for the preparation of a medicament for the treatment and/or prevention of scleroderma in particular of systemic , sclerosis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 30, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 30, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 30, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 30, 2001
GrantedNo grant recorded
Term endedNovember 30, 2021
Patent numberCA 2428092 A1
Classification (IPC)A61K48/00 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.